Biological warfare, bioterrorism, and biocrime

Clinical Microbiology and Infection

Volumn 20, Issue 6, 2014, Pages 488-496

  Jansen, H J ^a   Breeveld, F J ^b   Stijnis, C ^a,b   Grobusch, M P ^b  

^a Ministerie van Defensie   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biocrime; Biological agents; Biological warfare; Bioterror; Bioterrorism; Bioweapons

Indexed keywords

BIOCRIME; BIOLOGICAL WARFARE; CRIME; EDUCATION; HUMAN; INFECTION; PRIORITY JOURNAL; REVIEW; TERRORISM; TRAINING; TREND STUDY; ANIMAL; BIOLOGICAL WARFARE AGENT; CIVIL DEFENSE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; PLANT; PROCEDURES;

BIOLOGICAL WARFARE AGENT;

ANIMALS; BIOLOGICAL WARFARE; BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; CIVIL DEFENSE; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; HUMANS; PLANTS;

EID: 84904388476     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12699     Document Type: Review

References (55)

1. The Protocol for the Prohibition of the Use in War of Asphyxiating, Poisonous or Other Gases, and of Bacteriological Methods of Warfare. United Nations (1925).
2. World Health Organization. Public health response to biological and chemical weapons-WHO guidance, 2nd edn. Geneva: WHO, 2004.
3. Withers BG, Craig SC. The historical impact of preventive medicine in war. In: Kelly PW, ed. Textbooks of military medicine. Military preventive medicine: mobilization and deployment, Vol. 1. Washington, DC: Borden Institute, 2003; 21-57.
4. Leland A, Oboroceanu MJ. American war and military operations casualties: lists and statistics. CRS Report RL32492. Washington, DC: Congressional Research Service, 2010. Available at: www.crs.gov (last accessed 16 June 2014).
5. Walter Reed Army Medical Center. Personal protective measures against insects and other arthropods of military significance. Armed Forces Pest Management Board-Technical Guide 36. Washington, DC: Walter Reed Army Medical Center, 2002.
6. Robertson AG. From asps to allegations: biological warfare in history. Mil Med 1995; 160: 369-373.
7. Christopher G, Cieslak TJ, Pavlin JA et al. Biological warfare: a historical perspective. JAMA 1997; 278: 412-417.
8. Martin JW, Christopher GW, Eitzen EM. History of biological weapons: from poisoned darts to intentional epidemics. In: Dembek ZF, ed. Textbooks of military medicine. Medical aspects of biological warfare. Washington, DC: Borden Institute, 2007; 1-20.
9. Nuclear Threat Initiative. Available at: http://www.nti.org/country-profiles (last accessed 17 April 2014).
10. Atlas RM. The medical threat of biological weapons. Crit Rev Microbiol 1998; 24: 157-168.
11. Leitenberg M, Zilinskas RA, eds. The Soviet biological weapons program: a history. Cambridge, MA: Harvard University Press, 2012.
12. Centers for Disease Control and Prevention. Webpage Emergency Preparedness and Response. Specific hazards: Bioterrorism. Available at: http://www.bt.cdc.gov/bioterrorism (last accessed 16 June 2014).
13. Carus WS. Bioterrorism and biocrimes: the illicit use of biological agents since 1900. February 2001 revision. Washington, DC: Center for Counterproliferation Research, National Defense University, 2001. Available at: http://www.fas.org/irp/threat/cbw/carus.pdf (last accessed 16 June 2014).
14. Ackermann GA, Moran KS. Bioterrorism and threat assessment. Weapons of Mass Destruction Commission. Paper no. 22, 2004. Available at: www.blixassociates.com/wp-content/uploads/2011/03/No22.pdf (last accessed 16 June 2014).
15. Dando M. Bioterrorism: what is the real threat? Science and Technology Report No. 3. UK Global Health Policy Programme. London: The Nuffield Trust, 2005.
16. Kolavic SA, Kimura A, Simons SL et al. An outbreak of Shigella dysenteriae Type 2 among laboratory workers due to intentional food contamination. JAMA 1997; 278: 396-398.
17. Wheelis M, Casagrande R, Madden LV. Biological attack on agriculture: low-tech, high-impact bioterrorism. Bioscience 2002; 52: 569-576.
18. Bourn J. The 2001 Outbreak of Foot and Mouth Disease. Report by the Comptroller and Auditor General, HC 939 Session 2001-2002. London, UK: National Audit Office, 2002. Available at: www.nao.gov.uk (last accessed 16 June 2014).
19. Meuwissen MPM, Van Boven M, Hagenaars TJ et al. Predicting future costs of high-pathogenicity avian influenza epidemics: large versus small uncertainties. NJAS 2006; 52: 195-205.
20. Schmitt K, Zacchia NA. Total decontamination cost of the anthrax letter attacks. Biosecur Bioterror 2012; 10: 1-10.
21. Roxas-Duncan VI, Smith LA. Ricin perspective in bioterrorism. In: Morse SA, ed. Bioterrorism. Rijeka, Croatia: InTech, 2012; 133-158.
22. Franz DR, Jahrling PB, Friedlander AM et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399-411.
23. Inglesby TV, Henderson DA, Bartlett JG et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999; 281: 1735-1745.
24. Henderson DA, Inglesby TV, Bartlett JG et al. Smallpox as a biological weapon: medical and public health management. JAMA 1999; 281: 2127-2137.
25. Inglesby TV, Dennis DT, Henderson DA et al. Plague as a biological weapon: medical and public health management. JAMA 2000; 283: 2281-2290.
26. Arnon SS, Schechter R, Inglesby TV et al. Botulinum toxin as a biological weapon. Medical and public health management. JAMA 2001; 285: 1059-1070.
27. Dennis DT, Inglesby TV, Henderson DA et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001; 285: 2763-2773.
28. Broussard LA. Biological agents: weapons of warfare and terrorism. Mol Diagn 2001; 6: 323-333.
29. Borio L, Inglesby T, Peters CJ et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002; 287: 2391-2405.
30. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-231.asp (last accessed 16 June 2014).
31. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of plague and bioterrorism-related plague. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-232.asp (last accessed 16 June 2014).
32. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of smallpox and bioterrorism-related smallpox. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-233.asp (last accessed 16 June 2014).
33. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-234.asp (last accessed 16 June 2014).
34. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-235.asp (last accessed 16 June 2014).
35. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-236.asp (last accessed 16 June 2014).
36. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-237.asp (last accessed 16 June 2014).
37. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-238.asp (last accessed 16 June 2014).
38. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-239.asp (last accessed 16 June 2014).
39. Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of bioterrorism-related viral encephalitis. Euro Surveill 2004; 9. Available at: http://www.eurosurveillance.org/em/v09n12/0912-240.asp (last accessed 16 June 2014).
40. Fong IW, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York, NY: Springer, 2005.
41. Dembek Z, ed. Medical aspects of biological warfare. Textbooks of military medicine. Washington, DC: Borden Institute, 2007.
42. Dembek ZF, ed. Medical management of biological casualties handbook, 7th edn. Fort Detrick, Frederick, MD: US Army Medical Research Institute of Infectious Diseases, 2011. Available at: www.usamriid.army.mil/education/instruct.cfm (last accessed 16 June 2014).
43. Pinson L, Johns M, Ackerman G. Ricin Letters Mailed to President and Senator. National Consortium for the Study of Terrorism and Responses to Terrorism, 2013.
44. Török TJ, Tauxe RV, Wise RP et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 1997; 278: 389-395.
45. Crowe K. Salad bar salmonella. The Forensic Examiner, 2007; 16. BioMed Search Acc. nr. 165192830. 22 June 2007. Available at: http://www.biomedsearch.com/article/Salad-bar-Salmonella/165192830.html (last accessed 17 April 2014).
46. Henderson DA. The looming threat of bioterrorism. Science 1999; 283: 1279-1282.
47. Bleek PC. Revisiting Aum Shinrikyo: new insights into the most extensive non-state biological weapons program to date. Nuclear Threat Initiative 2011. Available at: http://www.nti.org/analysis/articles/revisiting-aum-shinrikyo-new-insights-most-extensive-non-state-biological-weapons-program-date-1 (last accessed 23 April 2014).
48. FBI 2010 Available at: http://www.fbi.gov/about-us/history/famouscases/anthrax-amerithrax (last accessed 16 April 2014).
49. National Research Council. Review of the scientific approaches used during the FBI's investigation of the 2001 Anthrax letters. Washington, DC: The National Academies Press, 2011.
50. Hall MJ, Norwood AE, Ursano RJ et al. The psychological impacts of bioterrorism. Biosecur Bioterror 2003; 1: 139-144.
51. Reissman DB, Whitney EAS, Taylor TH et al. One-year health assessment of adult survivors of Bacillus anthracis infection. JAMA 2004; 291: 1994-1998.
52. DiGiovanni C. Domestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry 1999; 156: 1500-1505.
53. Leitenberg M. Assessing the biological weapons and bioterrorism threat. Carlisle, PA: Strategic Studies Institute, US Army War College, 2005. Available at: http://www.strategicstudiesinstitute.army.mil/Pubs/display.cfm?PubID=639 (last accessed 23 April 2014).
54. Grushkin D, Kuiken T, Millet P, eds. Seven myths & realities about do-it-yourself biology. Synthetic Biology Project. Washington, DC: Wilson Center, 2013.
55. Suk JE, Zmorzynska A, Hunger I et al. Dual-use research and technological diffusion: reconsidering the bioterrorism threat spectrum. PLoS Pathog 2011; 7: e1001253.